Sanofi is has struck a five-year strategic alliance with drug discovery company Evotec – which will also be a boost for Evotec's partners, as the company will gain access to Sanofi's library of more than 1 million small molecules.
The French drug maker will commit €250m to Evotec, to be paid out over the next five years; this includes...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
